Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol use ...

New research presented May 17 at the American Psychiatric Association's Annual Meeting shows that GLP-1 receptor agonists may ...

While GLP-1 receptor agonists like semaglutide help with weight loss, new research shows users often fall short on vital nutrients, spotlighting the urgent need for tailored dietary guidance.

Early animal studies have indicated that GLP-1 drugs can help cut alcohol cravings, but studies involving humans are only starting to emerge, researchers said. For this study, researchers tracked ...

A new study found that GLP-1 drugs significantly reduce cancer risk associated with obesity — even more so than getting weight loss surgery. REUTERS Published in the Lancet’s eClinicalMedicine ...

Share on Pinterest A new study shows GLP-1 drugs liraglutide ... Wegovy is approved for use in weight management. Semaglutide drugs are available as both oral tablets and injections.

lower-dose care model to U.S. employers seeking sustainability As GLP-1 adoption grows among U.S. employers, the study points to a path toward meaningful outcomes without escalating drug costs.

People booze a lot less when taking GLP-1 drugs like Ozempic, a new study out of Ireland ... statistics show. Monkey Business – stock.adobe.com Harmful alcohol use accounts for about 2.6 million ...

Yet GLP-1 drugs represented less than 20% of Hims & Hers revenue in 2024 while hair-loss products for both men and women enjoyed phenomenal growth. In Q4, Hims Derm saw 55% year-over-year ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in ...

34,366 people played the daily Crossword recently. Can you solve it faster than others?34,366 people played the daily Crossword recently. Can you solve it faster than others?